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Trophoblast stem cells (TSCs) arise from the first cell
fate decision in the developing embryo and generate
extra-embryonic lineages, giving rise to the fetal
portion of the placenta. Mouse embryonic and ex-
tra-embryonic lineages are strictly separated by a
distinct epigenetic barrier, which is not fully over-
come following expression of TSC-determining fac-
tors in embryonic stem cells. Here, we show that
transient expression of Tfap2c, Gata3, Eomes, and
Ets2 is sufficient to reprogram mouse embryonic
fibroblasts and post-natal tail-tip-derived fibroblasts
into induced TSCs (iTSCs) and surmount the epige-
netic barrier separating somatic from extra-embry-
onic lineages. iTSCs share nearly identical morpho-
logical characteristics, gene expression profiles,
and DNA methylation patterns with blastocyst-
derived TSCs. Furthermore, iTSCs display trans-
gene-independent self-renewal, differentiate along
extra-embryonic lineages, and chimerize host pla-
centas following blastocyst injection. These findings
provide insights into the transcription factor net-
works governing TSC identity and opportunities for
studying the epigenetic barriers underlying embry-
onic and extra-embryonic lineage segregation.
INTRODUCTION
The totipotent zygote develops into inner and outer blastomeres,
which are the precursors of the future embryonic and extra-
embryonic lineage, respectively. Once lineage segregation
has taken place, cells are restricted to their respective cell
fates through reciprocal expression of factors antagonizing the
opposed fate (Kuckenberg et al., 2010; Niwa et al., 2005; Ralston
and Rossant, 2008; Strumpf et al., 2005). At the late blastocyst
stage, epigenetic modifications (such as DNA methylation)Cellestablish stable lineage barriers (Ng et al., 2008; Senner et al.,
2012).
Murine trophoblast stem cells (TSCs) are derived from the tro-
phectoderm (TE) of pre-implantation embryos or post-implanta-
tion trophoblast tissue. When cultured in the presence of FGF4/
heparin and TGFb/Activin, either supplied directly or through
culture in murine embryonic fibroblast (MEF)-conditioned media
(CM), TSCs remain in an undifferentiated, self-renewing state
(Erlebacher et al., 2004; Tanaka et al., 1998). When deprived of
those signals, they recapitulate placental development in vitro,
differentiating into all derivatives of the extra-embryonic tropho-
blast lineage (Simmons and Cross, 2005; Tanaka et al., 1998).
As such, they represent a stable stem cell population where early
lineage segregation between inner cell mass—the source of em-
bryonic stem cells (ESCs)—and TE can be studied. The analysis
of mammalian wild-type and mutant conceptuses has provided
considerable insights into the networks regulating the formation
and maintenance of this lineage. This led to the identification
of well-studied determinants of trophoblast cell fate, like the
caudal-type homeobox gene Cdx2 (Strumpf et al., 2005),
the product of the T-box gene Eomes (Russ et al., 2000), and
the ETS (E26 transformation specific)-domain transcription
factor Elf5 (Ng et al., 2008). Additionally, we and others have
contributed to deciphering this network through the forced
expression of single transcription factors in murine (m)ESCs,
pushing the cells toward a TSC-like (TSL) state, integrating fac-
tors like Cdx2, Eomes, Tfap2c, Gata3, and Ets2 (Kuckenberg
et al., 2010; Niwa et al., 2005; Odiatis and Georgiades, 2010;
Ralston et al., 2010; Wen et al., 2007).
Since the groundbreaking work of Takahashi and Yamanaka
(2006), it is known that cell fate conversion can be achieved
not only in cells of the early embryo, but also in differentiated
somatic cells. They have proven that the forced expression of
four transcription factors suffices to induce pluripotent stem
cells (iPSCs) from fibroblasts (Takahashi and Yamanaka, 2006).
The generated iPSCs can then be differentiated into a variety
of different cell types. A process termed ‘‘direct conversion’’
was demonstrated a few years later by Vierbuchen et al.
(2010), who used a combination of lineage defining transcription
factors to directly induce neurons from MEFs. In general, in vitroStem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier Inc. 557
Figure 1. 6F Suffices to Induce Transdifferentiation of MEFs into iTSCs
(A) Schematic of transdifferentiation approach. The 12 trophoblast-inducing factors (12F mix) under the control of a dox inducible promoter were transduced in
MEFs. The MEFs were expanded, re-plated in TS medium containing FGF4/heparin and dox. The transgene expression was activated for 10 days. The single
colonies were manually isolated and plated in TS-CM medium (30% TS medium, 70% MEF-conditioned medium, and FGF4/heparin).
(A0) Photomicrograph of a representative colony after 12F transduction and 10 days of dox induction in MEFs. The arrows indicate surrounding giant cells. The
scale bar represents 100 mm.
(B) Photomicrographs depictingmorphology of three iTSC lines with respective transgene integration. The transgenes common to all three clones are highlighted
in bold. The scale bar represents 100 mm. The integration of individual factors was detected by genotyping PCR (data not shown).
(legend continued on next page)
558 Cell Stem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier Inc.
manufactured cells offer a possibility to analyze clinically rele-
vant cell types with limited accessibility, such as neurons or
cardiomyocytes. Recently however, it has become evident that
cell populations engineered either by reprogramming of cells
into iPSCs and subsequent differentiation or by direct conver-
sion retain some of the epigenetic marks of their cell of origin
and represent intermediates in terms of cell fate (Cahan et al.,
2014; Kim et al., 2010; Morris et al., 2014; Ohi et al., 2011;
Polo et al., 2010). Similar to these results, recent data indicate
that TSL-fate induced by forced expression ofCdx2,Oct4 down-
regulation, and/or conditional extracellular signal-regulated
kinase 1/2 (Erk1/2) activation in ESC is not fully established, as
key TSC factors are not expressed to the expected levels and
morphological characteristics of TSCs are not stablymaintained.
Analysis of the epigenetic profile of TSL cells further corrobo-
rates this finding, sincemethylation of key trophoblast promoters
remains incompletely reprogrammed with levels intermediate
between ESCs and TSCs (Cambuli et al., 2014). In this study,
we determined the trophoblast-inducing potential of transcrip-
tion factors in a different setting. We used fibroblasts and
demonstrate that expression of a defined set of factors suffices
to fully convert them into self-renewing, functional TSCs, termed
induced (i)TSCs. iTSCs grow in the absence of transgene induc-
tion and strongly resemble regular TSCs inmorphology and gene
expression patterns. Further, iTSCs display a global methylation
signature highly similar to bona fide TSCs. Most importantly, key
loci representing lineage defining genes are demethylated and
expressed in iTSCs to levels comparable to TSCs. Generated
iTSCs differentiate into all sub-types of the trophoblastic lineage
in vitro, form hemorrhagic lesions in vivo, and are able to chimer-
ize the placenta, when injected into blastocysts, corroborating
their full conversion and functionality.
RESULTS
Screening for Trophoblast-Inducing Factors
To assess whether fibroblasts can be reprogrammed not only
into ESC-like iPSCs, but also into TSCs, thereby overcoming
the very first lineage barrier to be established in development,
we followed an approach akin to that of Takahashi and Yama-
naka (2006) by selecting a cohort of relevant trophoblast factors.
The primary lentiviral cocktail of potential trophoblast-inducing
factors consisted mainly of transcription factors known to play
important roles in the establishment and maintenance of
TSCs during development. Among the candidate factors were
those proven to have TSC induction potential when ectopically
expressed in mESCs (Cdx2, Eomes, Elf5, Tead4-VP16ER, and
Tfap2c, see Kuckenberg et al., 2010; Ng et al., 2008; Nishioka
et al., 2009; Niwa et al., 2005) and/or those essential for TSC
derivation (Cdx2, Elf5, Tfap2c, Ets2, and Tead4, see Donnison
et al., 2005; Kuckenberg et al., 2010; Nishioka et al., 2008;
Strumpf et al., 2005; Wen et al., 2007). Additionally, we consid-
ered factors that are differentially expressed at the initial stages
of lineage segregation (Tfap2a and Id2) (Guo et al., 2010) (for a full(C and D) RT-qPCR analyses of indicated TSC and fibroblast marker genes in TS
three independent RNA preparations. The expression is normalized by Gapdh an
(E) Immunofluorescence staining of Cdx2 in iTSC clone 6F-A and TSCs. The inset
and Table S2.
Celllist of candidate factors see Table S1). In order to establish a gain
of function model, we introduced single cDNAs of the candidate
genes into lentiviral pLV-tetO vectors and utilized a doxycycline
(dox) inducible system allowing for the temporal control of trans-
gene expression (Figure 1A).
Induction of iTSCs
MEFs were cultured in regular media and transduced with a
cocktail of 12 trophoblast-inducing factors (12F mix). Thereafter,
media was switched to TS medium, supplemented with FGF4/
heparin, and transgene expression was induced transiently
through dox administration (2 mg/ml) for 10 days (Figure 1A). At
this time point, morphologically distinct colonies emerged. RT-
quantitative (q)PCR analysis measuring the timing of endoge-
nous Cdx2 expression indicated a detectable Cdx2 level at day
6 of dox induction, which was increasing on subsequent days
of reprogramming (Figure S1A). Of note, during the same time
period, no expression of pluripotency markers Pou5f1 (Oct4) or
Nanog was detected (Figure S1B). Additionally, immunofluores-
cence staining against Oct4 was performed every day during this
time window.We did not detect Oct4 positive cells (for represen-
tative images see Figure S1C), indicating that 12F-MEFs do not
transit through a pluripotent intermediate. Dox was omitted after
day 10, leading to downregulation of the transgenes and hence
selection of colonies which had successfully established the
expression of endogenous TSC maintenance factors. After
further culture until day 14–21, colonies of transdifferentiated
cells appeared proliferative and were surrounded by polyploid
cells resembling trophoblast giant cells (TGCs) (Figure 1A’,
arrows). Such colonies were never observed on control dishes
(untransduced or mCherry transduced MEFs cultured in the
presence of dox or on dishes without dox-mediated transgene
induction). Single colonies were manually isolated and cultured
in media supplemented with FGF4/heparin and MEF-condi-
tioned medium. After sub-culture, colonies appeared epithelial,
with tight boundaries resembling typical TSC morphology
(Figure 1B). Thus, we concluded that a combination of factors
in the 12F mix is able to induce colonies with trophoblast
morphology.
In order to characterize the generated clones, we analyzed
endogenously expressed markers of undifferentiated TSCs.
Using RT-qPCR, we could demonstrate that the levels of TSC
markers (Cdx2, Elf5, Eomes, and Tfap2c) were comparable to
TSCs, but differed between individual clones (Figure 1C). Of
note, all analyzed clones ceased to express fibroblast specific
protein 1 (Fsp1, also named S100a4), a gene encoding a cal-
cium-binding protein specific for fibroblasts (Strutz et al., 1995)
(Figure 1D). In order to narrow down the number of transcription
factors required for induction of TSC-fate, we genotyped seven
12F-transduced iTSC clones for transgene integration (Fig-
ure 1B; Table S2). Clone 6F-A, which had integrated only Tfap2c,
Gata3, Eomes, Ets2, Tead4-VP16, and Tpbpa, was highly similar
to TSCs with regard to morphology (Figure 1B), endogenous
expression levels of TSCmarkersCdx2, Elf5, Eomes, and Tfap2cCs, parental 12F-MEFs, and iTSCs. The bars represent mean values ± SEM of
d Pgk1.
s display Hoechst staining. The scale bars indicate 100 mm. See also Figure S1
Stem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier Inc. 559
(Figure 1C), and immunofluorescence staining for Cdx2 (Fig-
ure 1E). We used this 6F-cocktail and obtained clones, which
displayed integration of four factors (4F) only (Tfap2c, Gata3,
Eomes, and Ets2).
This 4F-combination was able to induce endogenous Cdx2
and Elf5 expression after 10 days dox administration. Cdx2
levels were even higher compared to 6F or 12F transductions.
Of note, when transduced individually, only Tfap2c was able to
moderately induce expression of Cdx2 (Figure S1D).
Endogenous Cdx2 expression in bulk-transduced 4F-MEFs
was first detectable after 4 days of transgene expression and
reached levels similar to TSCs on day 10 (Figure S1E). The latter
was confirmed on protein level by immunofluorescence staining
(Figure S1F). Next, we aimed to determine theminimal number of
factors to induce TSC transdifferentiation. Therefore, we trans-
duced all combinations of the 4F, but did not obtain iTSCs with
fewer than four transgenes. Furthermore, all of the clones incu-
bated with the 4F virus mix had integrated all factors (n = 25,
example depicted in Figure S2A). Hence, by using this approach,
we found that lentivirally delivered transgenic Tfap2c, Gata3,
Eomes, and Ets2 are sufficient for the transdifferentiation of
fibroblasts into iTSC.
Characterization of 4F-iTSCs Derived from MEFs and
Tail Fibroblasts
Generation of 4F-iTSCs was highly reproducible, with 64 ± 10
transdifferentiated colonies per 10 cm dish, corresponding to
an average transdifferentiation efficiency of 0.03% as calculated
from the number of transdifferentiated areas per number of
plated cells (Figure S2B). However the transdifferentiation effi-
ciency is only an approximation, as it is highly dependent on
the transduction efficiency. Efficiency of iTSC derivation from
transdifferentiated areas was determined at passage two after
sub-culture and was up to 92%. Further, these iTSCs stained
positive for Cdx2 in all cases (n = 11) (Figure S2C).
We obtained 25 individual clones from five independent
transdifferentiation experiments following overexpression of
Tfap2c, Gata3, Eomes, and Ets2 and randomly choose five for
in-depth characterization (Figure 2A) after culture for at least
ten passages in the absence of dox induction. To test for chro-
mosomal aberrations, we performedmetaphase-spreads. There
were three clones that were euploid (4F-iTSC A, C, and D), one
displayed a mild aneuploidy with the majority of cells having
40 chromosomes (4F-iTSC B) and one clone harbored major ab-
normalities in chromosome number (4F-iTSC E) (Figure S2D).
Consequently, 4F-iTSC E was excluded from further analyses.
Immunofluorescence stainings on 4F-induced clones against
Tfap2c, Cdx2, Elf5, and Eomes confirmed conversion into iTSCs
(Figure 2B). The Tfap2c and Eomes proteins are most likely
endogenously expressed, since RT-qPCR analysis on 4F-iTSC
clones revealed absence of transgene expression (Figure 2C).
Absence of Pou5f1 (Oct4) transcript was verified by RT-qPCR,
confirming that 4F-iTSCs do not expressmarkers of pluripotency
(Figure S2E).
Primary fibroblasts have limited proliferation capacity. At
passage five most cells are in G1 phase, as demonstrated by
flow cytometry based propidium iodide staining (Figure 2D).
In contrast, in self-renewing TSCs, 50% of the population is in
S phase. Cell-cycle distributions of 4F-iTSCs were highly similar560 Cell Stem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier Into TSCs, indicating that they had adapted to the constant prolif-
eration indicative of self-renewal.
In order to further validate 4F-iTSCs, wemeasured expression
of cell surface marker Cd40 by flow cytometry. Cd40 was
identified as a surface antigen expressed on TSCs, which can
be used to separate TSCs from other stem cells of the early
embryo (ESCs or XEN cells) (Rugg-Gunn et al., 2012). Since
MEFs are negative for this surface marker as well, Cd40 ex-
pression was indicative for acquired TSC-fate of the induced
4F-iTSCs. All analyzed clones displayed high reactivity for
Cd40, when analyzed by flow cytometry with no significant
differences compared to TSCs (one-way ANOVA, Dunnett
post-test, p value R 0.05; Figure 2E). Next, we asked whether
the cells were able to grow in serum-free TX medium, a defined
medium for culture of TSCs (Kubaczka et al., 2014). The
4F-iTSCs gained a more homogenous TSC morphology (Fig-
ure S2F) and retained expression of TSC transcription factors
(Tfap2c, Cdx2, Eomes, and Elf5) and the surface marker Cd40
(Figures S2G and S2H). In contrast, incompletely converted,
transgene-dependent cells, which were isolated in previous ex-
periments could not bemaintained in TXmedia (data not shown).
These findings demonstrate that TX media selectively promotes
TSC-fate and that 4F-iTSCs indeed completed the conversion
process.
In order to rule out the unlikely possibility that 4F-MEF derived
iTSCs arise from trophoblast cells contaminating the MEF prep-
aration, we derived fibroblasts from tails of newborn mice (TFs)
and converted them into iTSCs using the same protocol as for
generation of MEF-derived iTSCs. Upon transgene induction,
there was no significant difference in endogenous Cdx2 or Elf5
induction in 4F-TFs compared to 4F-MEFs (Figure S3A). How-
ever, after 3 weeks, the number of transdifferentiated areas
was significantly reduced compared to 4F-MEFs (Figure S3B).
Nevertheless, sub-cultured transdifferentiated areas gave rise
to colonies with a striking resemblance to TSCs (Figure S3C)
displaying Cd40 (Figure S3D), Cdx2, and Tfap2c staining (Fig-
ure S3E). This indicates that Tfap2c, Eomes, Gata3, and Ets2
induced conversion toward iTSCs is not limited to embryonic
fibroblasts.
Finally, the long-term stability of the 4F-iTSCs was tested.
In total, five MEF-derived and two TF-derived iTSC lines
were cultured up to passage 40–50, displaying no changes in
Cd40 expression over time (Figure 2F). Throughout passaging,
4F-iTSCs maintained high expression of TE markers Cdx2,
Eomes, and Elf5 on RNA and protein level and kept TSC
morphology, confirming that the TSC fate was stably acquired
(Figures S3F and S3G).
Global DNA Methylation and Expression Profiling
of 4F-iTSCs
To assess the extent of epigenetic reprogramming, we used
4F-MEFs, TS-EGFP, and 4F-iTSCs for immunoprecipitation
of 5-methylcytosine (5mC) followed by high-throughput
sequencing (meDIP-seq) as published (Cambuli et al., 2014;
Kubaczka et al., 2014; Senner et al., 2012). We then compared
autosomal CpG island methylation between control TS-EGFP
cells and parental 4F-MEFs or 4F-iTSCs, as analysis of this
genomic feature allows for faithful prediction of lineage identity
(Senner et al., 2012). Globally, CpG island methylation of bonac.
Figure 2. Characterization of 4F-iTSC Clones
(A) Photomicrographs displaying colony morphology of 4F-iTSCs and TSCs. The scale bars represent 100 mm.
(B) Immunofluorescence staining of 4F-iTSCs against the trophoblast markers Tfap2c, Cdx2, Eomes, and Elf5. The insets display Hoechst staining. The scale
bars represent 100 mm.
(C) RT-qPCR analysis of transgene expression in 4F-iTSC clones at passage ten after sub-culture. The 4F-transduced MEFs cultured in the presence of dox
served as control. The bars represent mean values of three biological replicates ± SEM.
(D) DNA content measurement by PI staining and flow cytometric analysis. The bar graphs represent mean values of three biological replicates ± SEM.
(E) 4F-iTSCs are positive for Cd40 surface antigen. The exemplary histogram depicting the gating of Cd40 positive cells, with parental 4F-MEFs cultured without
dox plotted in gray. The black curve represents TSCs and the blue curve represents 4F-iTSC clone A. The bar graphs depict mean values ± SEM of triplicate
experiments for TSCs, untransduced MEFs, 4F-MEFs, and four 4F-iTSC clones (one-way ANOVA against +ctrl (TSCs) was performed with Dunnett post-test)
(p% 0.0001***).
(F) 4F-iTSCs maintain Cd40 surface antigen expression over extended culture periods. At each passage, three biological replicates were measured. See also
Figures S2 and S3.fide TS-EGFP cells was much more similar to 4F-iTSC clone B
(R = 0.912) than to the parental 4F-MEFs (R = 0.715) (Figures
3A and 3B). When comparing all 4F-iTSC clones to 4F-MEFs
and control TS-EGFP and TS6.5 (Kubaczka et al., 2014), as wellCellas ESCs, all transdifferentiated iTSCs cluster closely to genuine
TSCs (Figure 3C).
Next, we analyzed the methylation status of 11 differentially
methylated regions (DMRs), which are under tight epigeneticStem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier Inc. 561
Figure 3. Epigenetic Profiling of 4F-iTSCs
(A and B) Scatter plots displaying Pearson’s
correlation of autosomal CpG island methylation
between control TS-EGFP cells versus 4F-MEFs
(A) or 4F-iTSC clone B (B). Each point corresponds
to a CpG island. The values were normalized for
total read count and converted to a log2 scale.
(C) A neighbor joining tree, based on a Pearson’s
correlation distance matrix of autosomal CpG
island methylation profiles, reveals close similarity
of the 4F-iTSC lines to control TS-EGFP cells.
(D) A heat map representing promoter methy-
lation of key trophoblast genes ascertained by
MassArray analysis. The methylation levels of
4F-iTSC clone promoters are very similar to control
TS-EGFP.
(E) DNA methylation patterns as determined by
meDIP-seq at the Elf5 locus, which is hypo-
methylated in TSCs and iTSCs (example clones
B and D), but methylated in the parental 4F-MEFs.
(F) RT-qPCR analyses of trophoblast DMR
genes and key lineage markers Cdx2 and Thy1
in TSCs, 4F-MEFs, 4F-iTSC clones A–D, and
ESCs (ES J1). The expression of DMR genes and
Cdx2 is detected in all analyzed 4F-iTSCs. The
data are displayed relative to TSC expression
levels (TS-EGFP). The bars represent mean
values ± SEM of three biological replicates. See
also Figure S4.control between ESCs and TSCs. The DMRs of Elf5, (Ng et al.,
2008), as well as nine additional genes recently identified by
Cambuli et al. (2014) (Tead4, Hand1, Ezr, Lasp1, Map3k8,
Plet1, Rin3, Sh2d3c, and Tinagl1), are methylated and repressed
in embryonic cells but unmethylated and expressed in tropho-
blast. In addition, we analyzed the DMR of the pluripotency
marker Oct4 (Pou5f1), which is known to be methylated in
TSCs (Kuckenberg et al., 2011). MassARRAY analysis revealed
that like in ESCs, all loci are methylated in fibroblasts (Fig-
ure S4A). The trophoblast lineage specific DMRs underwent
demethylation in all analyzed 4F-iTSC, while methylation of
the Oct4 DMR remained unchanged. A heat map representing
the promoter methylation demonstrates high similarity to
TS-EGFP cells (Figure 3D). Next, we compared our data to the
results from TSL cells obtained by downregulation of Oct4,
forced expression of Cdx2, combined with activation of Erk1/2
signaling in ESCs (Cambuli et al., 2014). The dendrogram clearly562 Cell Stem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier Inc.indicates that MEF-derived 4F-iTSCs are
highly similar to TSCs and display a
more authentic genetic and epigenetic
signature compared to the ESC based re-
programming models (Figure S4B). Inter-
estingly, comparison of global promoter
binding analyses (Kidder and Palmer,
2010) with ten differentially methylated
key lineage genes (Cambuli et al., 2014)
revealed that Tfap2c and Eomes used
in the 4F-iTSC approach both bind to
Tead4, Elf5, Lasp1, and Hand1 (Fig-
ure S4C), underlining the importance
of these two reprogramming factors inTSC-fate induction (Cambuli et al., 2014; Kidder and Palmer,
2010). The role in the transdifferentiation process of the other
two components of the 4F cocktail, Gata3 and Ets2, remains
to be analyzed. Elf5 promoter demethylation in 4F-iTSCs was
further confirmed by meDIP-seq (Figure 3E), as well as by lo-
cus-specific bisulfite sequencing (Figure S4D). The experiments
further indicated that there is a group of CGIs, which are hypo-
methylated in MEFs when compared to TSC (which presents
as a ‘‘hump’’ in the scatter plot in Figure 3A). A heat map of these
selected CGIs (i.e., those that display the greatest differences
between MEFs and TSC) further demonstrates that the iTSCs
gain methylation at these loci during the reprogramming process
and become highly similar to TSCs (Figure S4E). Gene ontology
analysis of these CGIs demonstrated an enrichment of Homeo-
box genes and processes linked to embryonic development
(Figure S4F), as we had observed before in the analysis of
ESCs and TSCs (Senner et al., 2012).
Figure 4. 4F-iTSC Expression Profiling
(A) A heat map depicting Illumina expression array
results for parental 4F-MEFs, TS-EGFP cells, and
4F-iTSC clones A and D. The samples are from
three individual RNA preparations for 4F-MEFs and
4F-iTSCs and two in the case of TS-EGFP cells.
(B) Hierarchical clustering showing that 4F-iTSC
samples cluster closely to TSCs and apart from the
parental 4F-MEFs.
(C) Pair-wise scatter plot of 4F-iTSC clone A versus
TS-EGFP cells. The transcripts with higher
expression in TSCs are depicted in green; the
transcripts with lower expression are depicted in
red; and the key trophoblast transcription factors
are highlighted in orange. The overall gene
expression profile of 4F-iTSCs is highly similar to
TS-EGFP cells, with only very few transcripts dis-
playing differential expression (FC 2; log2 scale).
See also Table S3.Next, we tested whether hypomethylation of the lineage spe-
cific DMR genes correlated with their expression in 4F-iTSCs.
Indeed, all factors analyzed were expressed in 4F-iTSCs, albeit
not in all cases as strongly as in TS-EGFP cells (Figure 3F). A
possible explanation might be that some cells in culture are
more prone to spontaneous differentiation, leading to a hetero-
geneous cell population. Additionally, expression of the key
trophoblast factor Cdx2 in all 4F-iTSCs and downregulation of
the fibroblast specific transcript Thy1 were indicative of faithful
conversion into iTSCs (Figure 3F).
To further analyze expression profiles of iTSCs, we chose two
clones for transcription profiling by Illumina microarray analysis.
4F-iTSCs and TS-EGFP cells revealed a remarkably high similar-
ity in overall gene expression (Figure 4A), clustering closely to the
TSC samples and apart from the parental 4F-MEFs (Figure 4B).
Importantly, key TSCmarkers (Tead4,Cdx2,Gata3, Elf5, Eomes,
and Ets2) were not differentially expressed between 4F-iTSC
clones and TSCs (Figure 4C). In total, only 17 commonly upregu-
lated transcripts in both iTSC clones compared to TSCs were
found and five transcripts (including EGFP) were commonly
downregulated (Table S3). Taken together, these results demon-
strate that MEFs can be fully converted into iTSCs, which are
almost indistinguishable from bona fide TSCs.
4F Overexpression in ESCs
Since so far all attempts to induce fully converted TSCs from
ESCs seem to result in an incomplete conversion reflected by
the failure to completely demethylate the DMRs of TSC-specificCell Stem Cell 17, 557–568,genes (Cambuli et al., 2014), we asked
whether the 4F Tfap2c, Gata3, Eomes,
and Ets2 induce a more faithful reprog-
ramming toward TSCs when overex-
pressed in ESCs. We utilized the inducible
Tfap2c-ESC line (Kuckenberg et al., 2010)
and transduced it with Gata3, Eomes, and
Ets2 lentiviral vectors. Sub-clones were
isolated and transgene expression was
confirmed upon dox administration (Fig-
ure S5A). There were three independenti4F-ESC lines that were used for transdifferentiation approaches
toward TSCs. After transgene induction, all i4F-ESCs rapidly
inducedmorphological changes toward TSL-cells. Epithelial col-
ony morphology appeared already at day 3 of culture under TSC
conditions, while control iTfap2c-ESCs only started to change
morphology (Figure S2B). RT-qPCR analysis confirmed expres-
sion of endogenous Cdx2 and Elf5, however, i4F-ESCs failed
to reach levels of TSCs, even when transgene induction was
extended to 7 days (Figure S5C and data not shown). Most
importantly, TSL-morphology could not be propagated after
passaging, suggesting that the strategy used for fibroblasts
cannot be transferred to ESC without further adaptations.
4F-iTSCs Differentiate In Vitro and In Vivo into all
Trophoblast Derivatives
When cultured in absence of FGF4/heparin and CM, TSCs
undergo differentiation accompanied by increasing formation of
cells with DNA content higher than 4N (Tanaka et al., 1998).
Following the switch to differentiation media, three 4F-iTSC
clones displayed changes in ploidy indicative of trophoblast
differentiation, highly similar to what is seen in TSCs (Figure 5A).
These observations are in line with the appearance of polyploid
TGCs (Figure 5B, arrows). To explore whether iTSCs differentiate
into all sub-types of the trophoblastic lineage, we monitored
changes in gene expression upon differentiation. Analyzed iTSCs
rapidly downregulated the expression of Cdx2 and upregulated
markers of terminally differentiated TGCs (Tpbpa, Prl3d1,
Prl3b1,Prl2c2, andCtsq) in a timedependentmanner (Figure 5C).November 5, 2015 ª2015 Elsevier Inc. 563
Figure 5. In Vitro and In Vivo Differentiation Potential of 4F-iTSCs
(A) PI cell-cycle analysis of TSCs and three 4F-iTSCs cultured in the presence and absence of CM and FGF4/heparin. The cells were analyzed on day 0, 2, 4, and
6. The diploid (2N), tetraploid (4N), and octaploid (8N) DNA contents are indicated.
(B) Photomicrographs of TSCs and example 4F-iTSC clone C. The white arrows point at TGCs. The scale bars represent 100 mm.
(C) RT-qPCR analysis of indicatedmarker genes in differentiated (days 3 and 6) TSCs and 4F-iTSCs, normalized to expression in undifferentiated cells (day 0). The
bar graphs represent mean values ± SEM of three individual differentiation experiments.
(D) 4F-iTSCs or control MEFs were injected subcutaneously into both flanks of nude mice and lesions were analyzed 7 days after injection under a dissection
microscope and after fixation by H&E staining and IHC staining against the endothelial marker Cd31 and the trophoblast marker Tfap2c. The upper image
shows photographs of one out of six representative injections for 4F-iTSCs. The lower image shows photographs of one out of two representative injections
of MEFs.
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Figure 6. Placental Chimerization of 4F-
iTSCs
Photographs of chimeric placentas following
blastocyst injection of EGFP transduced 4F-iTSC
clone D on E10.5 (A) and E18.5 (B). The placentas
are shown from the embryo-facing side. The 4F-
iTSCs contributed to the placenta, but not to the
embryo proper. The white dotted line indicates line
of dissection of placenta displayed in the lower
image. The bisected placentas were placed in a
drop of agarose for stabilization in order to allow for
image capture of cross section (EGFP, green
channel and bright field, bf). The scale bars
represent 1 mm. See also Figure S6. (C) Table
summarizing number of chimeric placentas at
indicated time points after injection of either 4F-
iTSC clone A or D or control TS-EGFP cells. See
also Figure S6.To investigate the in vivo differentiation potential of 4F-iTSCs,
4F-iTSC clones were subcutaneously transplanted into nude
mice. There they formed transient hemorrhagic lesions, mimick-
ing the physiological behavior of TGCs in the developing
placenta as is seen after injection of TSCs (Kubaczka et al.,
2014; Kuckenberg et al., 2011). After 7 days, invasion of TGCs
into blood vessels was confirmed by H&E staining and immuno-
histochemical (IHC) staining of Tfap2c and the endothelial
marker Cd31 (Figure 5D, upper). Fibroblasts cultured under the
same conditions served as controls and were never observed
to invade into blood vessels (Figure 5D, lower).
To further access the in vivo potential of 4F-iTSCs, clones A
andDwere transducedwith an EGFP expressing lentiviral vector
and injected into blastocysts, while TS-EGFP cells served as
control. Conceptuses were analyzed on embryonic day of devel-
opment (E)7.5, E10.5 (Figures 6A and S6A), and E18.5 (Figures
6B and S6B) for EGFP expression. EGFP fluorescence was
detected on all analyzed time points after 4F-iTSC blastocyst in-
jections. Extent of the EGFP signal at E18.5 (Figure 6B, compare
to Figure S6B) indicated that the injected cells contributed to all
layers of the placenta. Of note, while the rate of chimerization is
comparable to the control at day E7.5 and E18.5 (14% and 9%,
respectively), the rate at E10.5 seems to be higher in controls
(Figure 6C). A general decrease in placental chimerization rates
at later developmental stages has been published before (Oda
et al., 2009). Neither 4F-EGFP-iTSCs nor TS-EGFP cells were
detected in the embryo proper. Taken together, in vitro and
in vivo results corroborate the full conversion of 4F-induced
MEFs to functional iTSCs.
DISCUSSION
Here, we demonstrate that the transient, ectopic expression of
transcription factors Tfap2c,Gata3, Eomes, and Ets2 is sufficient
to overcome the lineage barrier between embryonic and extra-
embryonic cells inducing stable and functional TSCs, which
maintain TSC morphology, even when grown in the absence of
a supportive layer of MEFs in defined culture conditions. OnceCellthe transcriptional network of TSCs is robustly activated, estab-
lished iTSCs are transgene independent and stable formore than
40 passages.
In 2010, Kidder and Palmer began deciphering the transcrip-
tion factor network governing TSC maintenance. By analyzing
genome-wide chromatin immunoprecipitation with DNA micro-
array hybridization in TSC, they developed a model where
Tfap2c and Eomeswere central to the TSC network. Both factors
co-occupied the largest number of target genes and were
shown to auto-regulate their own expression, as well as inducing
Gata3 expression (Kidder and Palmer, 2010). Our group has
further strengthened the role of Tfap2c in TE development.
It was demonstrated that Tfap2c induces trophoblast fate in
ESCs even in the absence of Cdx2 expression (Kuckenberg
et al., 2010). We are now able to expand this view by demon-
strating that Tfap2c, Eomes, Gata3, and Ets2 are able to induce
TSC-fate in fibroblasts.
Despite the fact that Cdx2 has been discussed as a master
regulator of the trophoblast lineage, exogenous Cdx2 is dispens-
able for the transdifferentiation. This is in line with results
obtained from ESC to TSC differentiation, where either downre-
gulation of Pou5f1 (Oct4) or overexpression of Tfap2c leads to
TSC induction even in the absence of Cdx2 (Kuckenberg et al.,
2010; Niwa et al., 2000). Additionally, Ralston et al. (2010) placed
Gata3 in parallel with Cdx2 downstream of Tead4 in early
mammalian development. Both factors have many common
targets, with Gata3 being able to induce more ‘‘core trophoblast
genes’’ than Cdx2 (Ralston et al., 2010). We hypothesize that in
our setting, Gata3, in combination with the other three factors,
is able to orchestrate initiation of trophoblast fate, eventually
leading to the activation of endogenous Cdx2 expression. This
interpretation is supported by the fact that Cdx2 has several
Ets-binding sites and has been shown to be a direct target of
Ets2 (Wen et al., 2007). The Cdx2 levels of MEF-induced iTSCs
are comparable to TSCs, emphasizing its role in maintaining
the undifferentiated state rather than inducing TSC-fate (Wu
et al., 2010). During blastocyst development, Cdx2 is required
for the restriction of the pluripotency factors Oct4 and NanogStem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier Inc. 565
to the ICM (Strumpf et al., 2005). Due to the fact that fibroblasts
do not express pluripotency factors, we hypothesize that Cdx2 is
dispensable in this setting to induce TSC-fate. An alternative
interpretation is that ectopic expression of Cdx2 in somatic cells
pushes the cell into a different cell fate distinct from TSCs. In fact,
a recent publication suggests that Cdx2 is a powerful inducer of
endoderm progenitors (Morris et al., 2014). Unexpectedly, Ets2,
and not Elf5, is among the final 4F used for iTSC induction. How-
ever, Ets2 has a known role in trophoblast development, since
mice deficient for Ets2 die before E8.5 and display defects in
trophoblast differentiation (Yamamoto et al., 1998) and impaired
extra-embryonic ectoderm (ExE) development (Georgiades and
Rossant, 2006). In addition, interference with Ets2 expression in
TSCs leads to decreased proliferation and increased differentia-
tion (Odiatis and Georgiades, 2010). Recent evidence suggests
that both ETS-domain transcription factors Ets2 and Elf5 have
partially overlapping roles (Donnison et al., 2015). It remains to
be analyzed whether Ets2 has an additional general effect on
transdifferentiation, as its overexpression together with MESP1
suffices for the direct conversion of human dermal fibroblasts
into cardiac progenitors (Islas et al., 2012).
In this study, we were not able to induce iTSCs with less than
4F. This might be due to the relatively brief induction of trans-
genes for 10 days. It cannot be ruled out that even fewer factors
are sufficient to induce iTSCs from fibroblasts when longer trans-
gene induction is performed or a different combination of factors
is applied.
In 2013, Chen et al. (2013) analyzed the direct induction of
trophoblast progenitor cells (iTP) from human fibroblasts. Since
TSCs are well established in mice, but not in human, it is difficult
to validate the experiments due to lack of a positive control.
Furthermore, the established iTP cells were not tested on their
transgene independence. Additionally, analyzed clones did not
display demethylation of the Elf5 promoter, which has been
shown to be a conserved feature in murine and human tropho-
blast (Hemberger et al., 2010; Ng et al., 2008). Taken together,
our study offers a broader phenotypic and functional character-
ization of directly converted TSCs, expanding the characteriza-
tion by functional assays demonstrating blood vessel invasion
after subcutaneous injection and placental chimerization upon
blastocyst injection.
We analyzed the MEF-induced 4F-iTSCs in terms of tropho-
blast marker gene expression, methylation status of key DMRs,
and differentiation potential. Variations in quality between indi-
vidual clones may be attributed to stoichiometry of integrated
factors, which could be analyzed through quantitative genotyp-
ing. Ultimately, a transgenic mouse line harboring a polycistronic
expression cassette of the 4F integrated in a single locus will be
more informative and aiding in understanding the MEF to iTSC
conversion process.
A recent publication compared different systems of direct in-
duction of TSCs from ESCs. Cambuli et al. (2014) demonstrated
that none of the analyzed systems, i.e., overexpression of Cdx2,
downregulation of Pou5f1 (Oct4), or activation of the Erk1/2, on
its own or in combination with Cdx2 induction, were able to fully
convert ESCs into TSCs. Importantly, they identified functionally
relevant genes that are similar to the already known Elf5, meth-
ylated and therefore repressed in ESCs, but hypomethylated
and expressed in TSCs. This set of genes offers reliable indica-566 Cell Stem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier Intors of trophoblast cell fate. Interestingly, 4F-MEF-derived iTSCs
display a higher similarity to bona fide TSCs compared to all
previously analyzed transgenic approaches from ESCs. Also,
while we were able to obtain stable iTSCs from MEFs, our 4F
reprogramming strategy was less potent when employed on
ESCs. An explanation for this discrepancy could be that epige-
netically, TSCs are closer to MEFs than ESCs. This hypothesis
is indeed corroborated by the DNA methylation levels at the
ten indicative genes described in Cambuli et al. (2014) that
show a lower, more TSL methylation level in MEFs than in
ESCs (Figure S4A); it is further supported by whole genome
analyses comparing promoter methylation in ESCs, TSCs, and
primary MEFs, which indicated that promoter methylation of
TSCs is more similar to that seen in MEFs than in ESCs (Farthing
et al., 2008). The question remains if this is due to a tighter epige-
netic barrier in pluripotent and multipotent stem cells derived
from earlier developmental stages compared to differentiated
somatic cells (fibroblasts). Considering that already small pertur-
bations in Oct4 expression levels lead to differentiation into
trophoblast or extra-embryonic endoderm (Niwa et al., 2000), it
stands to reason that lineage fixation during early embryonic
development must be very tight to prevent aberrant transdiffer-
entiation events.
It is now of great interest to gain deeper insights into the mo-
lecular mechanisms underlying the fibroblast to TSC conversion
and to determine the individual roles of transcription factors
involved in the transdifferentiation process. Here, we identify a
set of four transcription factors for iTSC induction from fibro-
blasts offering avenues into the analysis of transcription factor in-
teractions during the establishment of the trophoblastic lineage.
EXPERIMENTAL PROCEDURES
Cell Culture
Cells were grown on standard tissue culture plastic (TPP) in humidified incuba-
tors containing 7.5%CO2 at 37
C (Heraeus, Thermo Fisher Scientific). As con-
trol lines, TS-EGFP cells have been used (Tanaka et al., 1998), a kind gift of the
Rossant laboratory, Toronto, Canada. Additionally, an E6.5 derived TSC line
was used (TS6.5), which was generated in our laboratory and published before
(Kubaczka et al., 2014). 4F-iTSCs cultured in defined TX medium were grown
on Synthemax (Corning) as published before (Kubaczka et al., 2014).
Virus Production and Transduction
Single coding sequences of the 12 candidate factors were introduced into the
pLV-tetO vector, kindly provided by K. Hochedlinger (Harvard University).
Details regarding the cloning procedure are given in the Supplemental Informa-
tion. All vectors were sequence verified prior to use. Lentiviral production was
performed in 293T cells through co-transfection of lentivectors with VSV-G
(pMD2.G, Addgene number: 12259) and helper plasmid (psPAX2, Addgene
number: 12260) by calcium-phosphate precipitation. Virus containing superna-
tant was harvested 48 hr and 72 hr after transfection, filtered through 0.4 mm
SFCA membrane and frozen for further use. Transduction was performed on
6-well dishes overnight in the presence of 8 mg/ml polybrene (Sigma-Aldrich).
Cell Cycle Analysis
Cells cultured on 6-well dishes were dissociated by trypsin, fixed with 70%
ice-cold ethanol, washed, and re-suspended in propidium iodide (PI) staining
solution (50 mg/ml PI [BD]; 0.1% (v/v) Triton X-100 [Sigma-Aldrich]; and
0.2 mg/ml RNaseA [Sigma-Aldrich] in PBS) for 30 min at room temperature,
followed by flow cytometric analysis on a FACSCanto (BD Biosciences).
Cell-cycle distribution was determined using theWatson (Pragmatic) algorithm
in FlowJo Software (Tree Star) and statistic analysis was performed using one-
way ANOVA with Dunnett post-test comparing all samples to TSCs.c.
Flow Cytometric Analysis of Cd40 Expression
Cells were harvested with 0.05% trypsin/EDTA or Accutase (eBioscience), re-
suspended in fluorescence-activated cell sorting (FACS) buffer (2% FBS in
PBS) and filtered through a 40 mm cell strainer. There were 100,000 cells
that were transferred into a FACS tube and incubated with 0.4 mg/ml a-Cd40
antibody (R&D systems) for 30 min on ice. Cells were washed with FACS
buffer, re-suspended in FACS buffer with a-goat Alexa-488 or Alexa-647 anti-
body, and incubated for 20 min on ice in the dark. After washing, cells were re-
suspended in FACSbuffer with 1%7-amino-actinomycin D (BectonDickinson)
to discriminate live from dead cells. Staining was acquired on a FACSCanto
(BD Biosciences) and analyzed using FlowJo Software (Tree Star). p values
were calculated using one-way ANOVA.
Immunofluorescence Staining
Staining of cells was performed as published (Kubaczka et al., 2014). In brief,
cells were washed with PBS, fixed for 10 min with 4% paraformaldehyde
(Sigma-Aldrich), permeabilized with 0.5% (v/v) Triton X-100 in PBS, and incu-
bated in blocking buffer (2% BSA and 0.1% Triton X-100 in PBS). Primary
antibodies were incubated overnight. Antibody dilutions are given in Table S4.
RNA Isolation and Analysis
RNA was isolated from cells using either TRI Reagent (Sigma) or RNeasy Mini
Kit (QIAGEN) according to the manufacturer’s protocol. There were 500 to
1,000 ng total RNA that were used for cDNA synthesis by RevertAid Premium
(Fermentas, Thermo Scientific). RT-qPCR was performed on ViiA 7 (Applied
Biosystems, Life Technologies) using Maxima SYBR Green Master Mix (Fer-
mentas, Thermo Scientific). For primer sequences, see Table S3. Expression
of target genes was normalized to the indicated reference gene. In case of
multiple reference genes, normalization was performed on the geometric
mean of all reference genes. Each reaction was performed in triplicate. Micro-
array analysis using MouseWG-6 v2.0 Expression BeadChip (Illumina) was
performed with 200 ng total RNA. RNA quantity was determined on a Nano-
Drop 1000 spectrometer (Thermo Fisher Scientific) and quality was measured
on a 2100 Bioanalyzer (Agilent Technologies). After amplification with the
TotalPrep-96 RNA Amplification Kit (Illumina), hybridization was performed
according to manufacturer’s recommendations. Variance stabilization was
performed using the log2 scaling data post-processing and graphics were per-
formed with in-house developed functions in Matlab. Hierarchical clustering
of genes and samples was performed with one minus correlation metric and
the unweighted average distance (UPGMA) (also known as group average)
linkage method.
DNA Methylation Profiling
Genome-wide DNA methylation profiles of 4F-MEFs, 4F-iTSCs, and TS-EGFP
cells were analyzed by meDIP-seq as described previously (Senner et al.,
2012). Briefly, purified genomic DNA was sonicated to yield 150–600 bp
fragments and adaptors for paired-end sequencing (Illumina) were ligated
using the NEBNext DNA Library Prep Master Mix Kit (New England Biolabs).
Immunoprecipitations (IPs) were carried out in duplicate using 500 ng DNA
per sample, 1.25 mg anti-5mC antibody (Eurogentec), and 10 ml Dynabeads
coupled with M-280 sheep anti-mouse IgG (Invitrogen). The two IPs were
pooled and amplified for 12 cycles with adaptor specific primers with index
tags for multiplexing (Quail et al., 2012), run on a 1% agarose gel and frag-
ments ranging between 300 and 500 bp in size were cut out and purified using
the QIAGEN Gel Extraction Kit. Sequencing was carried out on an Illumina
HiSeq. Reads were mapped to the mouse genome build NCBIM37 and final
data analysis was performed using SeqMonk software. For MassArray anal-
ysis of individual promoters, DNA was bisulphite-treated using the QIAGEN
EpiTect Kit following manufacturer’s instructions. Regions of interest were
amplified and PCR products were processed using the MassCLEAVE Kit
(Sequenom) for MassArray analysis.
TSC Transplantation
TSC transplantations were performed as published (Kubaczka et al., 2014). In
brief, 5 3 106 TSCs, iTSCs, or MEF cells were re-suspended in 200 ml TS-CM
containing FGF4/heparin and were injected subcutaneously into 9-week-old,
male nudemice. After 7 days post-injection, implantation sites were dissected,
fixed in 4% paraformaldehyde overnight, embedded in paraffin, and sectionedCell(4 mm), followed by H&E staining and routine IHC protocols. Incubation
with primary a-Tfap2c antibody (1:500, 6E4/4, Santa Cruz) or a-CD31 (1:50,
Dianova) was performed for 30 min at room temperature. Signal detection
was performed semi-automatically in the Autostainer 480 S (Medac).
Blastocyst Injection
Prior to blastocyst injection, 4F-iTSCs were transduced with a lentiviral vector
(FUGW) driving EGFP expression under the UbiC promoter (Addgene plasmid
14883, see Lois et al., 2002). D2B6F2 blastocysts were injected with 12 to 20
4F-EGFP iTSCs or control TS-EGFP cells. Blastocysts were transferred into
pseudo-pregnant foster mice (CB6F1) and analyzed at E7.5, E10.5, or E18.5
for EGFP fluorescence.
Animal Studies
All experiments were conducted according to the German law of animal pro-
tection and in agreement with the approval of the local institutional animal
care committees (Landesamt fu¨r Natur, Umwelt und Verbraucherschutz, North
Rhine-Westphalia, approval ID number: AZ 84-02.04.2013.A428).
ACCESSION NUMBERS
High-throughput meDIP-seq and Illumina expression array data determined in
the course of this work were deposited in NCBI’s GEO database and are
accessible through GEO: GSE64145 and GEO: GSE64339, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and five tables and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2015.08.005.
AUTHOR CONTRIBUTIONS
C.K., C.E.S., and M.C. conducted experiments; M.J.A.B. performed the bio-
informatic analyses; C.K., P.K., M.P., and H.S. designed the study; and C.K.,
C.E.S., M.H., and H.S. interpreted data and wrote the manuscript.
ACKNOWLEDGMENTS
Weare extremely grateful to Angela Egert for blastocyst injections; Gaby Beine
and Susanne Steiner for excellent technical assistance; and Alexander Murray,
who generously provided primers for MassArray and RT-qPCR analysis. Addi-
tionally, we thank the Department of Genomics, Life andBrain Center, Bonn for
performing Illumina expression arrays and Eva Riechert for generating the
pLV-tetO-Eomes construct. This study was supported by DFG grant Scho
503/10-1.
Received: December 12, 2014
Revised: May 27, 2015
Accepted: August 6, 2015
Published: September 24, 2015
REFERENCES
Cahan, P., Li, H., Morris, S.A., Lummertz da Rocha, E., Daley, G.Q., and
Collins, J.J. (2014). CellNet: network biology applied to stem cell engineering.
Cell 158, 903–915.
Cambuli, F., Murray, A., Dean, W., Dudzinska, D., Krueger, F., Andrews, S.,
Senner, C.E., Cook, S.J., and Hemberger, M. (2014). Epigenetic memory of
the first cell fate decision prevents complete ES cell reprogramming into
trophoblast. Nat. Commun. 5, 5538.
Chen, Y., Wang, K., Gong, Y.G., Khoo, S.K., and Leach, R. (2013). Roles of
CDX2 and EOMES in human induced trophoblast progenitor cells. Biochem.
Biophys. Res. Commun. 431, 197–202.
Donnison, M., Beaton, A., Davey, H.W., Broadhurst, R., L’Huillier, P., and
Pfeffer, P.L. (2005). Loss of the extraembryonic ectoderm in Elf5 mutants leads
to defects in embryonic patterning. Development 132, 2299–2308.Stem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier Inc. 567
Donnison, M., Broadhurst, R., and Pfeffer, P.L. (2015). Elf5 and Ets2 maintain
the mouse extraembryonic ectoderm in a dosage dependent synergistic
manner. Dev. Biol. 397, 77–88.
Erlebacher, A., Price, K.A., and Glimcher, L.H. (2004). Maintenance of mouse
trophoblast stemcell proliferation by TGF-beta/activin. Dev. Biol. 275, 158–169.
Farthing, C.R., Ficz, G., Ng, R.K., Chan, C.-F., Andrews, S., Dean, W.,
Hemberger, M., and Reik, W. (2008). Global mapping of DNA methylation in
mouse promoters reveals epigenetic reprogramming of pluripotency genes.
PLoS Genet. 4, e1000116.
Georgiades, P., and Rossant, J. (2006). Ets2 is necessary in trophoblast for
normal embryonic anteroposterior axis development. Development 133,
1059–1068.
Guo, G., Huss, M., Tong, G.Q., Wang, C., Li Sun, L., Clarke, N.D., and Robson,
P. (2010). Resolution of cell fate decisions revealed by single-cell gene expres-
sion analysis from zygote to blastocyst. Dev. Cell 18, 675–685.
Hemberger, M., Udayashankar, R., Tesar, P., Moore, H., and Burton, G.J.
(2010). ELF5-enforced transcriptional networks define an epigenetically regu-
lated trophoblast stem cell compartment in the human placenta. Hum. Mol.
Genet. 19, 2456–2467.
Islas, J.F., Liu, Y., Weng, K.-C., Robertson, M.J., Zhang, S., Prejusa, A.,
Harger, J., Tikhomirova, D., Chopra, M., Iyer, D., et al. (2012). Transcription
factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into
cardiac progenitors. Proc. Natl. Acad. Sci. USA 109, 13016–13021.
Kidder, B.L., and Palmer, S. (2010). Examination of transcriptional networks re-
veals an important role for TCFAP2C, SMARCA4, and EOMES in trophoblast
stem cell maintenance. Genome Res. 20, 458–472.
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M.J., Ji,
H., Ehrlich, L.I.R., et al. (2010). Epigenetic memory in induced pluripotent stem
cells. Nature 467, 285–290.
Kubaczka, C., Senner, C., Arau´zo-Bravo, M.J., Sharma, N., Kuckenberg, P.,
Becker, A., Zimmer, A., Bru¨stle, O., Peitz, M., Hemberger, M., and Schorle,
H. (2014). Derivation and maintenance of murine trophoblast stem cells under
defined conditions. Stem Cell Reports 2, 232–242.
Kuckenberg, P., Buhl, S., Woynecki, T., van Fu¨rden, B., Tolkunova, E., Seiffe,
F., Moser, M., Tomilin, A., Winterhager, E., and Schorle, H. (2010). The tran-
scription factor TCFAP2C/AP-2gamma cooperates with CDX2 to maintain
trophectoderm formation. Mol. Cell. Biol. 30, 3310–3320.
Kuckenberg, P., Peitz, M., Kubaczka, C., Becker, A., Egert, A., Wardelmann,
E., Zimmer, A., Bru¨stle, O., and Schorle, H. (2011). Lineage conversion of mu-
rine extraembryonic trophoblast stem cells to pluripotent stem cells. Mol. Cell.
Biol. 31, 1748–1756.
Lois, C., Hong, E.J., Pease, S., Brown, E.J., and Baltimore, D. (2002). Germline
transmission and tissue-specific expression of transgenes delivered by lentivi-
ral vectors. Science 295, 868–872.
Morris, S.A., Cahan, P., Li, H., Zhao, A.M., San Roman, A.K., Shivdasani, R.A.,
Collins, J.J., and Daley, G.Q. (2014). Dissecting engineered cell types and
enhancing cell fate conversion via CellNet. Cell 158, 889–902.
Ng, R.K., Dean, W., Dawson, C., Lucifero, D., Madeja, Z., Reik, W., and
Hemberger, M. (2008). Epigenetic restriction of embryonic cell lineage fate
by methylation of Elf5. Nat. Cell Biol. 10, 1280–1290.
Nishioka, N., Yamamoto, S., Kiyonari, H., Sato, H., Sawada, A., Ota, M.,
Nakao, K., and Sasaki, H. (2008). Tead4 is required for specification of tro-
phectoderm in pre-implantation mouse embryos. Mech. Dev. 125, 270–283.
Nishioka, N., Inoue, K., Adachi, K., Kiyonari, H., Ota, M., Ralston, A., Yabuta,
N., Hirahara, S., Stephenson, R.O., Ogonuki, N., et al. (2009). The Hippo
signaling pathway components Lats and Yap pattern Tead4 activity to distin-
guish mouse trophectoderm from inner cell mass. Dev. Cell 16, 398–410.
Niwa, H., Miyazaki, J., and Smith, A.G. (2000). Quantitative expression of Oct-
3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat.
Genet. 24, 372–376.
Niwa, H., Toyooka, Y., Shimosato, D., Strumpf, D., Takahashi, K., Yagi, R., and
Rossant, J. (2005). Interaction between Oct3/4 and Cdx2 determines trophec-
toderm differentiation. Cell 123, 917–929.568 Cell Stem Cell 17, 557–568, November 5, 2015 ª2015 Elsevier InOda, M., Tanaka, S., Yamazaki, Y., Ohta, H., Iwatani, M., Suzuki, M., Ohgane,
J., Hattori, N., Yanagimachi, R., Wakayama, T., and Shiota, K. (2009).
Establishment of trophoblast stem cell lines from somatic cell nuclear-trans-
ferred embryos. Proc. Natl. Acad. Sci. USA 106, 16293–16297.
Odiatis, C., and Georgiades, P. (2010). New insights for Ets2 function in
trophoblast using lentivirus-mediated gene knockdown in trophoblast stem
cells. Placenta 31, 630–640.
Ohi, Y., Qin, H., Hong, C., Blouin, L., Polo, J.M., Guo, T., Qi, Z., Downey, S.L.,
Manos, P.D., Rossi, D.J., et al. (2011). Incomplete DNAmethylation underlies a
transcriptional memory of somatic cells in human iPS cells. Nat. Cell Biol. 13,
541–549.
Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y.,
Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T., et al. (2010). Cell type of origin
influences the molecular and functional properties of mouse induced pluripo-
tent stem cells. Nat. Biotechnol. 28, 848–855.
Quail, M.A., Otto, T.D., Gu, Y., Harris, S.R., Skelly, T.F., McQuillan, J.A.,
Swerdlow, H.P., and Oyola, S.O. (2012). Optimal enzymes for amplifying
sequencing libraries. Nat. Methods 9, 10–11.
Ralston, A., and Rossant, J. (2008). Cdx2 acts downstream of cell polarization
to cell-autonomously promote trophectoderm fate in the early mouse embryo.
Dev. Biol. 313, 614–629.
Ralston, A., Cox, B.J., Nishioka, N., Sasaki, H., Chea, E., Rugg-Gunn, P., Guo,
G., Robson, P., Draper, J.S., and Rossant, J. (2010). Gata3 regulates tropho-
blast development downstream of Tead4 and in parallel to Cdx2. Development
137, 395–403.
Rugg-Gunn, P.J., Cox, B.J., Lanner, F., Sharma, P., Ignatchenko, V.,
McDonald, A.C.H., Garner, J., Gramolini, A.O., Rossant, J., and Kislinger, T.
(2012). Cell-surface proteomics identifies lineage-specific markers of em-
bryo-derived stem cells. Dev. Cell 22, 887–901.
Russ, A.P., Wattler, S., Colledge, W.H., Aparicio, S.A., Carlton, M.B., Pearce,
J.J., Barton, S.C., Surani, M.A., Ryan, K., Nehls, M.C., et al. (2000).
Eomesodermin is required for mouse trophoblast development and meso-
derm formation. Nature 404, 95–99.
Senner, C.E., Krueger, F., Oxley, D., Andrews, S., and Hemberger, M. (2012).
DNAmethylation profiles define stem cell identity and reveal a tight embryonic-
extraembryonic lineage boundary. Stem Cells 30, 2732–2745.
Simmons, D.G., and Cross, J.C. (2005). Determinants of trophoblast lineage
and cell subtype specification in the mouse placenta. Dev. Biol. 284, 12–24.
Strumpf, D., Mao, C.-A., Yamanaka, Y., Ralston, A., Chawengsaksophak, K.,
Beck, F., and Rossant, J. (2005). Cdx2 is required for correct cell fate specifi-
cation and differentiation of trophectoderm in the mouse blastocyst.
Development 132, 2093–2102.
Strutz, F., Okada, H., Lo, C.W., Danoff, T., Carone, R.L., Tomaszewski, J.E.,
and Neilson, E.G. (1995). Identification and characterization of a fibroblast
marker: FSP1. J. Cell Biol. 130, 393–405.
Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells
from mouse embryonic and adult fibroblast cultures by defined factors. Cell
126, 663–676.
Tanaka, S., Kunath, T., Hadjantonakis, A.K., Nagy, A., and Rossant, J. (1998).
Promotion of trophoblast stem cell proliferation by FGF4. Science 282, 2072–
2075.
Vierbuchen, T., Ostermeier, A., Pang, Z.P., Kokubu, Y., Su¨dhof, T.C., and
Wernig, M. (2010). Direct conversion of fibroblasts to functional neurons by
defined factors. Nature 463, 1035–1041.
Wen, F., Tynan, J.A., Cecena, G., Williams, R., Mu´nera, J., Mavrothalassitis,
G., and Oshima, R.G. (2007). Ets2 is required for trophoblast stem cell self-
renewal. Dev. Biol. 312, 284–299.
Wu, G., Gentile, L., Fuchikami, T., Sutter, J., Psathaki, K., Esteves, T.C.,
Arau´zo-Bravo, M.J., Ortmeier, C., Verberk, G., Abe, K., and Scho¨ler, H.R.
(2010). Initiation of trophectoderm lineage specification in mouse embryos is
independent of Cdx2. Development 137, 4159–4169.
Yamamoto, H., Flannery, M.L., Kupriyanov, S., Pearce, J., McKercher, S.R.,
Henkel,G.W.,Maki,R.A.,Werb,Z., andOshima,R.G. (1998).Defective trophoblast
function in mice with a targeted mutation of Ets2. Genes Dev. 12, 1315–1326.c.
